Deltex Medical's H1 hurt by financial problems in the NHS

14th Jul 2015 12:35

(ShareCast News) - Deltex Medical Group fell on Tuesday after reveiling its UK market remained weak due to continuing NHS financial problems. The oesophageal Doppler monitoring (OMD) provider said its revenues in the UK declined 13% during the first half of the year and surgical probe revenues were

Read more

Deltex wins government funding for commercialisation

24th Jun 2015 13:30

Deltex Medical Group has secured funding from government backed organisation Innovate UK. It has won a grant for a project to commercialise a non-invasive approach to the acquisition of blood flow information from patients. The medical equipment producer estimates the grant is worth about £170,000

Read more

Deltex Medical appoints former auditor as finance director

23rd Jun 2015 08:25

Deltex Medical has appointed its former auditor of nearly four years as its new finance director. Jonathan Shaw, a member of the Financial Reporting Review Panel and specialist business mentor for Prince Charles' charity The Prince's Trust, will assume the role on 1 September. Previously, Shaw had

Read more

Deltex Medical pleased by findings of US hospital study

9th Jun 2015 14:52

Oesophageal doppler monitoring (ODM) specialist Deltex Medical Group has welcomed positive results from a study looking at the implementation of ODM in colorectal surgery. The findings have led the hospital where the study was carried out to recommend making the enhanced recovery protocols, includin

Read more

Deltex Medical annual loss widens during "difficult" 2014

11th Mar 2015 11:08

Deltex Medical Group said that product delays in its overseas markets and cash difficulties in the NHS weighed on its annual revenue, leading to wider pre-tax losses. The AIM-listed company said its pre-tax loss rose to £3.1m, a 40.9% increase year-on-year, as revenue declined 16.3% to £4.6m, in wha

Read more

Xaar's R&D Director builds stake following lower profit guidance

25th Jun 2014 15:50

Ramon Borrell, the Research & Development (R&D) Director of FTSE 250 member Xaar, continued to build his stake in the inkjet printheads supplier with the purchase of 40,000 shares. The deal comes just days after the company lowered its guidance for full-year revenues and profit margin, saying the

Read more

Sector movers: Bid target Smith & Nephew lifts healthcare as Medtronic enters the fray

5th Jun 2014 14:37

Ongoing M&A speculation boosted the share price of Smith & Nephew (S&N) on Thursday, giving the healthcare sector a lift, as another company was reported to be interested in the medical devices firm. According to Bloomberg which cited people familiar with the matter, US peer Medtronic is in the ear

Read more

Deltex Medical announces placing and open offer

22nd May 2014 14:34

Deltex Medical Group has announced plans to raise up to 4.7m pounds from a placing and open offer and warned first-half probe revenues would be hit by NHS destocking. The medical devices group aims to drum up £4m at 11p each from a placing, together with an open offer for existing shareholders at t

Read more

Sector movers: Mobile telecoms, healthcare stocks rise as results impress

6th Feb 2014 14:02

The mobile telecoms and healthcare categories were putting in decent performances on Thursday in London after results from sector heavyweights Vodafone and Smith & Nephew impressed. Vodafone gained 2.4% in afternoon trade after revenues declined by a less-than-expected 3.6% in the third quarter to

Read more

Deltex Medical eyes accelerated second half growth

9th Jul 2013 10:47

Deltex Medical said half year sales fell from the same period a year earlier but it expects to deliver accelerated growth over and above current levels as programmes start to come through in the second half of the year. The group, which provides blood flow monitors during and after operations, sa

Read more

Deltex Medical seeking to raise 2.5m pounds through share issue

18th Jan 2013 11:24

AIM-listed Deltex Medical, the maker of a technological device which can monitor blood flow during and after operations, has announced a placing of more than 13m shares so as to raise 2.5m pounds. The 13,157,895 new ordinary shares of one pence each are being placed by Arden Partners on behalf of D

Read more

Steppe Cement CEO builds on his stake

16th Oct 2012 17:05

Javier Del Ser, the Chief Executive Officer (CEO) of AIM-listed construction materials producer Steppe Cement, topped up his stake in the firm on Tuesday with the purchase of 650,000 ordinary shares at a price of 25p per share. Following the £162,500 transaction, Del Ser holds 12,867,660 ordinary s

Read more

Deltex Medical sees blood flow monitor sales double

2nd May 2012 11:23

Deltex Medical, the makers of a device which monitors blood flow during and after operations, says it is beginning to benefit from an official recommendation by the National Institute for Health and Clinical Excellence (NICE). In March last year NICE recommended that the CardioQ-ODM system be consi

Read more

Small caps round-up: TEG, Deltex, Ultrasis...

4th Apr 2012 09:12

Loss-making green technology company TEG Group has entered into a further contract with recycling firm Viridor to process additional volumes of green and food waste in TEG's network of facilities. The contract will run until April 2014. The revenue over the term of the contract will depend upon the

Read more

Small caps round-up: Green Compliance, Deltex Medical, Mouchel...

29th Mar 2012 11:39

Green Compliance, an AIM-listed provider of business support services, has reported a solid trading outcome for the year ended March 31st, in line with its expectations. The firm said that while it has not been immune to declines in the UK economy, is has won businesses and contracts throughout the

Read more